Tri Sprout Kratom Redefines Wellness in Las Vegas
LAS VEGAS, NV / ACCESSWIRE / January 27, 2024 / Tri Sprout Kratom, a Las Vegas deeply rooted in the...
Day: January 27, 2024
Sirona Biochem Initiates Private Placement
VANCOUVER, British Columbia, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V:SBM) (FSE: ZSB) (OTC: SRBCF) (the "Company") is...
Vision Sensing Acquisition Corp. Responds to NASDAQ Letter and Hopeful of Expedient Resolution
NEW YORK, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company” or “VSAC”),...
Daré Bioscience Announces Executive Team and Board of Directors Changes
SAN DIEGO, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today...
BrightSpring Celebrates First Day of Trading on Nasdaq
Will Make $100 Million Equity Grant to 20,000 EmployeesLOUISVILLE, Ky., Jan. 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc....
Autonomix Medical, Inc. Announces Closing of $11.2 Million in Gross Proceeds from Initial Public Offering
Shares to begin trading on NASDAQ on January 29, 2024 under the ticker symbol “AMIX” THE WOODLANDS, TX., Jan. 26,...
NADP and ADA Achieve Loss Ratio Compromise at NCOIL
Model legislation offers middle ground solution on loss ratiosDALLAS, Jan. 26, 2024 (GLOBE NEWSWIRE) -- The National Association of Dental...
AB Science announces an update in the marketing authorization application of masitinib in amyotrophic lateral sclerosis at the European Medicines Agency
PRESS RELEASE AB SCIENCE ANNOUNCES AN UPDATE IN THE MARKETING AUTHORIZATION APPLICATION OF MASITINIB IN AMYOTROPHIC LATERAL SCLEROSIS AT THE...
Zealand Pharma major shareholder announcement: Van Herk Investments
Company announcement – No. 6 / 2024 Zealand Pharma major shareholder announcement: Van Herk Investments Copenhagen, Denmark, 26 January 2024 – Zealand...
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
HANOVER, Md., Jan. 26, 2024 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical...
Patient Safety Movement Foundation’s Mid-Year Meeting Charts Course for Global Patient Safety Initiatives in 2024
IRVINE, Calif.--(BUSINESS WIRE)--The Patient Safety Movement Foundation (PSMF) convened its annual Mid-Year Event to discuss safety challenges in the healthcare...